All articles tagged with #himsandhers
Amazon is expanding its healthcare services by offering fixed pricing for treatments of conditions like erectile dysfunction and hair loss to Prime members, potentially disrupting competitors like Hims & Hers, whose stock dropped over 20% following the announcement. This move follows Amazon's acquisition of One Medical and PillPack, aiming to integrate healthcare into its services and boost Prime member retention.
Amazon has introduced fixed pricing for Prime members seeking treatment for conditions like erectile dysfunction and hair loss, intensifying competition with direct-to-consumer health companies like Hims & Hers, whose stock dropped 15% following the announcement. The new service offers telehealth consultations and discounted medications through Amazon Pharmacy, building on Amazon's healthcare initiatives, including its acquisition of One Medical and previous ventures like Amazon Care.
Several stocks are experiencing significant premarket movements, including Trump Media, Hims & Hers, and Palantir. These shifts are drawing attention from investors as they prepare for the trading day.
Hims & Hers Health's stock surged after the company reported strong earnings, driven by its compounded weight-loss drugs, including a version of Novo Nordisk's semaglutide. The company posted a 77% increase in sales year-over-year, surpassing expectations, and raised its sales outlook for the year. Hims & Hers now has over 2 million subscribers, with a significant portion using personalized solutions, contributing to its robust growth trajectory.